https://www.pharmanow.live/latest-news/probiogen-dr-simon-johannes-bulling-coo-appointment-biologics-cdmo
ProBioGen Appoints Dr. Simon Bulling as COO | Pharma Now
ProBioGen names Dr. Simon Johannes Bulling COO. His dual drug substance and drug product background has direct implications for CDMO GMP and process validation.
dr simonprobiogencoopharma
https://transkript.de/tag/probiogen-ag/
ProBioGen AG Archives - |transkript
probiogenagarchivestranskript
https://www.probiogen.de/press-releases/modex-therapeutics-leverages-probiogens-expertise-for-accelerated-covid-19-antibody-development
ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development
ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development - ProBioGen AG
https://www.probiogen.de/cdmo-services-for-proteins-antibodies/biosimiliars-biobetters
Biosimilars & Biobetters Development Services | ProBioGen AG
development servicesbiosimilarsprobiogenag
https://www.probiogen.de/press-releases/tag/commercialization
Press Releases | ProBioGen AG | commercialization
commercialization | ProBioGen AG Press Releases. Updates on ProBioGen and cover currently relevant topics on human biopharmaceuticals, notably on therapeutic...
press releasesprobiogenagcommercialization